CA Patent

CA2338498C — Process for the synthesis of (1h)-benzo[c]quinolizin-3-ones derivatives

Assigned to Merck Serono SA · Expires 2009-05-19 · 17y expired

What this patent protects

The present invention refers to a process for the preparation of (1H)-benzo[c]quinolizin-3-ones derivatives of general formula (I) which involves the three steps shown below and the use, as starting products, of commercially available, or easily preparable, compounds. The compoun…

USPTO Abstract

The present invention refers to a process for the preparation of (1H)-benzo[c]quinolizin-3-ones derivatives of general formula (I) which involves the three steps shown below and the use, as starting products, of commercially available, or easily preparable, compounds. The compounds of formula (I) are useful as inhibitors of 5.alpha.-reductases. wherein R1, R2, R3, R4, R5, are the same or different, and are selected from the group consisting of: H, C1-8alkyl, C2-8alkenyl, C2-8alkinyl, cycloalkyl, aryl, heterocycle, halogen, CN, azide, NRR', C1-8alkylamino, arylamino, C1-8alkyloxy, aryloxy, COOR, and CONRR' wherein R and R', are the same or different, and are selected from the group consisting of: H, C1-8alkyl, cycloalkyl, aryl, heterocycle, and arylC1-8alkyl; Q is selected from the group consisting of: a single bond, C1-8alkyl, C2-8alkenyl, C2-8alkinyl, cycloalkyl, CO, CONR, and NR, wherein R is as above defined; W is selected from the group consisting of: H, C1-8alkyl, C2-8 alkenyl, C2-8alkinyl, cycloalkyl, trifluoromethyl, C1-8alkoxy, C1-8 alkoxy-C1-8alkyl, arylC1-8alkyl, aryl, aryloxy, arylamino, C1-8alkylcarbonyl, arylcarbonyl, arylcarboxyl, arylcarboxyamide, halogen, CN, NRR', C1-8alkylamino, and heterocycle wherein the groups alkyl, alkenyl, alkinyl, cycloalkyl, aryl, and heterocycle, can be substituted; n is an integer comprised between 1 and 4; and X is selected from hydrochloride, sulphate, citrate, formiate and phosphate.

Drugs covered by this patent

Patent Metadata

Patent number
CA2338498C
Jurisdiction
CA
Classification
Expires
2009-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Merck Serono SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.